CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial The Role of the Pericardium in Heart Failure: Implications for Pathophysiology and Treatment Angiotensin–neprilysin inhibition versus enalapril in heart failure Outcomes and Effect of Treatment According to Etiology in HFrEF An Analysis of PARADIGM-HF Dilated cardiomyopathy: so many cardiomyopathies!

Guideline24 February 2021

JOURNAL:National Institue for Health and Care Excellence Article Link

Dapagliflozin for treating chronic heart failure with reduced ejection fraction

National Institue for Health and Care Excellence Keywords: HFrEF; guideline; NICE

Full Text PDF